GH Research PLC (GHRS)
12.04
+0.34
(+2.91%)
USD |
NASDAQ |
May 07, 16:00
12.04
0.00 (0.00%)
After-Hours: 20:00
GH Research Total Return Level: 11.70 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 11.70 |
May 03, 2024 | 11.68 |
May 02, 2024 | 11.19 |
May 01, 2024 | 11.95 |
April 30, 2024 | 10.96 |
April 29, 2024 | 10.75 |
April 26, 2024 | 10.51 |
April 25, 2024 | 10.50 |
April 24, 2024 | 11.08 |
April 23, 2024 | 11.30 |
April 22, 2024 | 11.72 |
April 19, 2024 | 11.03 |
April 18, 2024 | 11.19 |
April 17, 2024 | 10.99 |
April 16, 2024 | 10.99 |
April 15, 2024 | 11.72 |
April 12, 2024 | 11.19 |
April 11, 2024 | 11.00 |
April 10, 2024 | 11.05 |
April 09, 2024 | 11.09 |
April 08, 2024 | 11.06 |
April 05, 2024 | 11.14 |
April 04, 2024 | 11.02 |
April 03, 2024 | 10.99 |
April 02, 2024 | 11.04 |
Date | Value |
---|---|
April 01, 2024 | 11.08 |
March 28, 2024 | 10.66 |
March 27, 2024 | 10.71 |
March 26, 2024 | 11.09 |
March 25, 2024 | 10.55 |
March 22, 2024 | 10.77 |
March 21, 2024 | 10.59 |
March 20, 2024 | 11.00 |
March 19, 2024 | 10.89 |
March 18, 2024 | 10.81 |
March 15, 2024 | 10.90 |
March 14, 2024 | 10.17 |
March 13, 2024 | 10.30 |
March 12, 2024 | 9.25 |
March 11, 2024 | 8.36 |
March 08, 2024 | 8.11 |
March 07, 2024 | 8.18 |
March 06, 2024 | 8.46 |
March 05, 2024 | 8.50 |
March 04, 2024 | 8.13 |
March 01, 2024 | 8.50 |
February 29, 2024 | 8.88 |
February 28, 2024 | 8.23 |
February 27, 2024 | 8.72 |
February 26, 2024 | 8.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.26
Minimum
Dec 18 2023
27.90
Maximum
Nov 09 2021
12.96
Average
11.16
Median
Jun 08 2022
Total Return Level Benchmarks
Amarin Corp PLC | 0.98 |
Jazz Pharmaceuticals PLC | 109.85 |
Prothena Corp PLC | 23.75 |
Iterum Therapeutics PLC | 1.59 |
Mural Oncology PLC | 3.78 |